Interventions for perinatal hypoxic-ischemic encephalopathy

Pediatrics

Volumn 100, Issue 6, 1997, Pages 1004-1014

  Vannucci, Robert C ^a   Perlman, Jeffrey M ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; GLUCOCORTICOID; GROWTH FACTOR; MONOSIALOGANGLIOSIDE; OXYGEN RADICAL; PHENOBARBITAL; SCAVENGER;

ASPHYXIA; BRAIN DISEASE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; HUMAN; HYPERGLYCEMIA; HYPOTHERMIA; METABOLIC REGULATION; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW;

EID: 0030707511     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.6.1004     Document Type: Review

References (164)

1. Vannucci RC. Hypoxic-ischemic encephalopathy: clinical aspects. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. IV. Philadelphia, PA: Mosby-Yearbook, Inc; 1997:877-891
2. Vannucci RC. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1990;85: 961-968
3. Vannucci RC, Palmer C. Hypoxic-ischemic encephalopathy: pathogenesis and neuropathology. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. Philadelphia, PA: Mosby-Yearbook, Inc; 1997:856-877
4. Memezawa H, Minamisawa H, Smith M-L, et al. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res. 1992;89:67-78
5. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for program cell death in focal cerebral ischemia in rats. Stroke. 1993;24: 2002-2009
6. Macmanus JP, Buchan AM, Hill IE, et al. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett. 1993;164:89-92
7. Hossmann K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565
8. Horn M, Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol. 1992;85:79-87
9. Chiamulera C, Terron A, Reggiani A, et al. Qualitative and quantitative analysis of the progressive cerebral damage after middle cerebral artery occlusion in mice. Brain Res. 1993;606:251-258
10. Islam N, Aftabuddin M, Moriwaki A, et al. Detection of DNA damage induced by apoptosis in the rat brain following incomplete ischemia. Neurosci Lett. 1995;188:159-162
11. Goodwin TM, Belai I, Hernandez P, et al. Asphyxiai complications in the term newborn with severe umbilical acidemia. Am J Obstet Gynecol. 1992;162:1506-1512
12. Low JA, Panagiotopoulos C, Derrick EJ. Newborn complications after intrapartum asphyxia with metabolic acidosis in the term fetus. Am J Obstet Gynecol. 1994;170:1081-1087
13. Nelson KB, Dambrosia JM, Ting TY, et al. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med. 1996;334: 613-618
14. Perlman JM, Risser R. Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers? Pediatrics. 1996;97:456-462
15. Siesjö BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab. 1981;1:155-185
16. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-163
17. Nelson CW, Wei EP, Povlishock JT, et al. Oxygen radicals in cerebral ischemia. Am J Physiol. 1992;263:H1356-H1362
18. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624
19. Majewska M, Strosznajder J, Lazarewicz J. Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Res. 1978;158:423-434
20. Rehncroná S, Westerberg E, Akesson B, et al. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. Stroke. 1978;9:327-335
21. Bhakoo KK, Crockard HA, Lascelles PT. Regional studies of changes in brain fatty acids following experimental ischaemia and reperfusion in the gerbil. J Neurochem. 1984;43:1025-1031
22. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics. 1996;98:103-107
23. de Haan HH, Van Reempts JLH, Vles JSH, et al. Effects of asphyxia on the fetal lamb brain. Am J Obstet Gynecol. 1993;169:1493-1501
24. Inder TE, Graham P, Sanderson K, et al. Lipid peroxidation as a measure of oxygen-free radical damage in the very low birthweight infant. Arch Dis Child. 1994;70:107-111
25. Nishida A, Misaki Y, Kuruta H. Developmental expression of copper, zinc-superoxide dismutase in human brain by chemiluminescence. Brain Dev. 1994;16:40-44
26. Smith CV, Hansen TN, Martin NE, et al. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res. 1993;34: 360-364
27. Liu XH, Kato H, Araki T, et al. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat. Brain Res. 1994; 644:257-266
28. Armstead WM, Mirro R, Thelin OP, et al. Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets. Stroke. 1992;23:755-762
29. He YY, Hsu CY, Ezrin AM, et al. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia reperfusion. Am J Physiol. 1993;265:H252-H256
30. Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res. 1990;27: 332-336
31. Palmer C, Roberts RL. Reduction of perinatal brain damage with oxypurinol treatment after hypoxic-ischemic injury. Pediatr Res. 1991; 29:362. Abstract
32. Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res. 1993;33:405-411
33. Sasaki T, Nakagomi T, Kirino T, et al. Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector. Stroke. 1988;19:1399-1403
34. Pourcyrous N, Leffler CW, Bada HS, et al. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic dose. Pediatr Res. 1993;34:366-369
35. Beck T, Bielenberg GW. The effects of 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res. 1991;560:159-162
36. Bågenholm R, Andiné P, Hagberg H. Effects of 21-amino steroid tirilazad mesylate (U74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Pediatr Res. 1966;40:399-403
37. McRae A, Gilland E, Bona E, et al. Microglia activation after neonatal hypoxia-ischemia. Dev Brain Res. 1995;84:245-252
38. Towfighi J, Zec N, Yager J, et al. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Acta Neuropathol. 1995;90:375-386
39. Ivacko JA, Sun R, Silverstein FS. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res. 1996; 39:39-47
40. Liu X-H, Eun B-L, Silverstein FS, et al. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res. 1996;40:1-8
41. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111
42. Kass IS, Lipton P. Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice. J Physiol (Lond). 1982;332:459-472
43. Rothman SM. Synaptic activity mediates death of hypoxic neurons. Science. 1983;220:536-527
44. Novelli A, Reilly JA, Lysko PG, et al. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988;451:205-212
45. Coyle JT, Bird SJ, Evans RH, et al. Excitatory amino acid neurotoxins: selectivity, specificity and mechanism of action. Neurosci Res Prog Bull. 1981;19:329-427
46. McBean GJ, Roberts PJ. Chronic infusion of L-glutamate causes neurotoxicity in rat striatum. Brain Res. 1984;290:372-375
47. Steiner HX, McBean GJ, Kohler C, et al. Ibotenate-induced neuronal degeneration in immature rat brain. Brain Res, 1984;307:117-124
48. Pulsinelli WA. De-afferentation of the hippocampus protects CA1 pyramidal neurons against ischemic damage. Stroke. 1985;16:144. Abstract
49. Siesjö BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab. 1989; 9:127-140
50. Andiné P, Sandberg M, Bågenholm R, et al. Intra- and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxia-ischemia. Dev Brain Res. 1991;64:115-120
51. Silverstein FS, Naik B, Simpson J. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis study. Pediatr Res. 1991;30:587-590
52. Albers G, Goldberg MP, Choi DW. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol. 1989;25:398-403
53. McCulloch J. Amelioration of ischemic and hemorrhagic injury by pharmacological intervention. In: Lou HC, Greisen G, Larsen JF, eds. Brain Lesions in the Newborn: Hypoxic and Haemodynamic Pathogenesis. Munksgaard, Copenhagen: 1994;485-499
54. Sheardown MJ, Suzdak PD, Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischemia, even when delayed 24 hours. Eur J Pharmacol. 1993;236:347-353
55. McDonald JW, Silverstein FS, Johnston MW. Neuroprotective effects of MK-801, TCP, PCP, and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res. 1989;490: 33-40
56. McDonald JW, Silverstein FS, Johnston MV. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol. 1987;140: 359-361
57. Ford LM, Sanberg PR, Norman AB. Mk-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch Neurol. 1989;46:1090-1096
58. Hattori H, Morin AM, Schwartz PH, et al. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 1989;39:713-718
59. McDonald JW, Trescher WH, Johnston MV. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res. 1992;583:54-70
60. Hagberg H, Gilland E, Diemer N-H, et al. Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate. 1994;66:205-213
61. Greenamyre JT, Olson JMM, Penney JB, et al. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainatesensitive glutamate binding sites. J Pharmacol Exp Ther. 1985;233: 254-263
62. Greeyamyre JT, Penney JB, Young AB, et al. Evidence for transient perinatal glutamatergic innervation of globus pallidus. J Neurosci. 1987;7:1022-1030
63. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev. 1990;15:41-70
64. McDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990;109:234-238
65. Thordstein M, Bagenholm R, Thiringer K, et al. Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat. Pediatr Res. 1993;34:23-26
66. Marret S, Gressens P, Gadissiux J-F, et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain. An animal model for clinical intervention studies. Dev Med Child Neurol. 1995;37:473-484
67. de Hann HH, Gunn AJ, Williams CE, et al. Magnesium sulfate therapy during asphyxia in near-term fetal lambs does not compromise the fetus but does not reduce cerebral injury. Am J Obstet Gynecol. 1997; 176:18-27
68. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics. 1995;95: 263-269
69. Levene M, Blennow M, Whitelaw A, et al. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child. 1995;73:F174-F177
70. Vannucci RC. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr Res. 1990;27:317-326
71. Deshpande JK, Wieloch T. Flunarizine, a calcium entry blocker, ameliorates ischemic brain damage in the rat. Anesthesiology. 1986;64: 215-224
72. Alps BJ, Haas WK. The potential beneficial effect of nicardipine in a rat model of transient forebrain ischemia. Neurology. 1987;37:809-814
73. Germano IM, Bartkowski HM, Cassel ME, et al. The therapeutic value of nimodipine in experimental focal cerebral ischemia. J Neurosurg. 1987;67:81-87
74. Silverstein FS, Buchanan K, Hudson C, et al. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke. 1986;17:477-482
75. Gunn AJ, Mydlar T, Bennet L, et al. The neuroprotective actions of a calcium channel antagonist, flunarizine, in the infant rat. Pediatr Res. 1989;25:573-576
76. Gunn AJ, Williams CE, Mallard EC, et al. Flunarizine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr Res. 1994; 35:657-663
77. Levene MI, Gibson NA, Fenton AC, et al. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol. 1990;32:567-574
78. Johns RA. EDRF/nitric oxide. Anesthesiohgy. 1991;75:927-931
79. Dawson TM, Dawson DL, Snyder SH. A novel neuronal molecular message in brain: the free radical, nitric oxide. Ann Neurol. 1992;32: 297-311
80. Szabó C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull. 1996;41:131-141
81. Nowicki JP, Duval D, Poignet H, et al. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol. 1991;204:339-340
82. Maiese K, Wagner J, Boccone L. Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade. Neurosci Lett. 1994;166: 43-47
83. Ashwal S, Cole DJ, Osborne T, et al. Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J Neurosurg Anesthesiol. 1993;5:241-249
84. Kuluz JW, Prado RJ, Dietrich WD, et al. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke. 1993;24:2023-2029
85. Nishikawa T, Kirsch JR, Koehler RC, et al. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke. 1993;24:1717-1724
86. G-nitro-L-arginine in focal stroke in the 7-day old rat. Eur J Pharmacol. 1992;218:197-198
87. Hamada Y, Hayakawa T, Hattori H, et al. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res. 1994;35:10-14
88. Marks KA, Mallard CE, Roberts I, et al. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res. 1996;40:185-191
89. Molina Y, Vedia L, McDonald B, et al. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem. 1992;267:24929-24932
90. Granger DL, Lehninger AL. Sites of inhibition of mitochondrial electron transport in macrophage-induced neoplastic cells. J Cell Biol. 1982;95:527-535
91. Drapier J-C, Hibbs JC. Murine cytotoxic activated macrophages inhibits aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest. 1986;78:790-797
92. Toffano G, Benvegnu D, Bonetti AC. Interaction of GM1 ganglioside with crude rat brain neuronal membranes. J Neurochem. 1980;35: 861-866
93. Tan WKM, Williams CE, Gunn AJ, et al. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic-ischemic injury without causing systemic compromise. Pediatr Res. 1993;34:18-22
94. 1 treatment after a hypoxic-ischemic episode reduces the vulnerability of the fetal sheep brain to subsequent injuries. Am J Obstet Gynecol. 1994;170:663-670
95. Holtzman DM, Sheldon RA, Jaffe W, et al. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 1996;39:114-122
96. Cooper PR, Moody S, Clark WK, et al. Dexamethasone and severe head injury: a prospective double-blind study. J Neurosurg. 1979;51: 307-316
97. Gudeman SK, Miller JD, Becker DP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg. 1979;51:301-306
98. Dearden NM, Gisbon JS, McDowall DC, et al. Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg. 1986;64:81-88
99. Plum F, Alvord EC, Posner JB. Effect of steroids on experimental cerebral infarction. Arch Neurol. 1963;9:571-573
100. Donley RF, Sundt TM. Effect of dexamethasone on the edema of focal cerebral edema. Stroke. 1973;4:148-155
101. Lee MC, Mastri RA, Waltz AG, et al. Ineffectiveness of dexamethasone for treatment of experimental cerebral infarction. Stroke. 1974;5: 216-218
102. Altman DI, Young RSK, Yagel SK. Effects of dexamethasone in hypoxic-ischemic brain injury in the neonatal rat. Biol Neonate. 1984; 46:149-156
103. Kalayci O, Cataltepe S, Cataltepe O. The effect of bolus methylprednisolone in prevention of brain edema in hypoxic-ischemic brain injury: an experimental study in 7-day-old rat pups. Brain Res. 1992; 569:112-116
104. Barks JDE, Post M, Tuor UI. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res. 1991; 29:558-563
105. Chumas PD, Del Bigio MR, Drake JM, et al. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia. J Neurosurg. 1993;79:414-420
106. Tuor UI, Simone CS, Barks JDE, et al. Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke. 1993;24:452-457
107. Tuor UI, Simone CS, Arellano R, et al. Glucocorticoid prevention of neonatal hypoxic-ischemic damage: Role of hyperglycemia and antioxidant enzymes. Brain Res. 1993;604:165-172
108. Garite TJ, Rumney P, Briggs GG, et al. A randomized, placebocontrolled trial of betamethasone for prevention of respiratory distress syndrome at 24-48 weeks' gestation. Am J Obstet Gynecol. 1993;166: 646-651
109. Leviton A, Kuban KC, Pagano M, et al. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in inrubated low birthweight babies. Pediatrics. 1993;91:1083-1088
110. Kari M, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized, placebo-controlled, multicenter study. Pediatrics. 1994;93: 730-736
111. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactanttreated preterm infants. J Pediatr. 1995;126:272-279
112. Michenfelder JD, Milde JH, Sundt TM. Cerebral protection by barbiturate anesthesia: use after middle cerebral artery occlusion in Java monkeys. Arch Neurol. 1976;33:345-350
113. McGraw CP. Experimental cerebral infarction: effects of pentobarbital in Mongolian gerbils. Arch Neurol. 1977;34:334-336
114. Bleyaert AL, Nemoto EM, Safar P, et al. Thiopental amelioration of brain damage after global brain ischemia in monkeys. Anesthesiology. 1978;49:390-398
115. Levy DE, Brierley JB. Delayed pentobarbital administration limits ischemic brain damage in gerbils. Ann Neurol. 1979;5:59-64
116. Campbell AGM, Milligan JB, Talner NS. The effect of pretreatment with pentobarbital, meperidine or hyperbaric oxygen on the response to anoxia and resuscitation in newborn rabbits. J Pediatr. 1968;72: 518-527
117. Cockburn F, Daniel SS, Dawes GS, et al. The effect of pentobarbital anesthesia on resuscitation and brain damage in fetal rhesus monkeys asphyxiated on delivery. J Pediatr. 1969;75:281-291
118. Goodlin RC, Lloyd D. Use of drugs to protect against fetal asphyxia. Am J Obstet Gynecol. 1970;107:227-231
119. Wechsler RL, Dripps RD, Kety SS. Blood flow and oxygen consumption of the human brain during anesthesia produced by thiopental. Anesthesiology. 1951;12:308-312
120. Lowry OH, Passonneau JV, Hasselberger FX, et al. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J Biol Chem. 1964;239:18-30
121. Baughman VL, Huffman WE, Meletich DJ, et al. Effects of phenobarbital on cerebral blood flow and metabolism in young and aged rats. Anesthesiology. 1986;65:500-505
122. MacDonald RL, Barker JL. Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons. Science. 1978;200:775-777
123. Eyre JA, Wilkinson AR. Thiopentone induced coma after severe birth asphyxia. Arch Dis Child. 1986;61:1084-1089
124. Goldberg RN, Moscoso P, Bauer CR, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr. 1986;109:851-856
125. Ruth V, Virkola K, Paetau R, et al. Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. J Pediatr. 1988;112:81-86
126. Hall RT, Hall FK, Daily DK. High dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr. In press
127. Myers RE, Yamaguchi S. Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Arch Neurol. 1977;34:65-74
128. Kalimo H, Rehncroná S, Suderfeldt B, et al. Brain lactic acidosis and ischemic cell damage. II. Histopathology. J Cereb Blood Flow Metab. 1981;1:313-327
129. Pulsinelli WA, Waldman S, Rawlinson D, et al. Hyperglycemia converts neuronal damage into brain infarction. Neurology. 1982;32: 1239-1246
130. Pulsinelli WA, Levy DE, Sigsbee B, et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without diabetes mellitus. Am J Med. 1983;74:540-544
131. Vannucci RC, Mujsce DJ. The effect of glucose on perinatal hypoxic-ischemic brain damage. Biol Neonate. 1992;62:215-224
132. Voorhies TM, Rawlinson D, Vannucci RC. Glucose and perinatal hypoxic-ischemic brain damage in the rat. Neurology. 1986;36: 1115-1118
133. Vannucci RC, Brucklacher RM, Vannucci SJ. The effect of hyperglycemia on cerebral metabolism during hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab 1996;16:1026-1033
134. LeBianc MH, Huang M, Vig V, et al. Glucose affects the severity of hypoxic-ischemic brain injury in newborn pigs. Stroke. 1993;24: 1055-1062
135. Sheldon RA, Partridge JC, Ferriero DM. Postischemic hyperglycemia is not protective to the neonatal rat brain. Pediatr Res. 1992;32:489-493
136. Yager JY, Heitjan DF, Towfighi J, et al. Effect of insulin-induced and fasting hypoglycemia on perinatal hypoxic-ischemic brain damage. Pediatr Res. 1992;31:138-142
137. Cremer JE. Substrate utilization and brain development. J Cereb Blood Flow Metab 1982;2:394-407
138. Greisen G, Munck H, Lou H. Severe hypocarbia in preterm infants and neurodevelopmental deficit. Acta Pediatr Scand. 1987;76:401-404
139. Graziani L, Spitzer AR, Mitchell DG, et al. Mechanical ventilation in preterm infants: neurosonographic and developmental studies. Pediatrics. 1992;90:515-522
140. Ikonen RS, Janas MO, Koidikko MJ, et al. Hyperbilirubinemia, hypocarbia and periventricular leukomalacia in preterm infants: Relationship to cerebral palsy. Acta Pediatr Scand. 1992;81:802-807
141. Vannucci RC, Towfighi J, Heitjan DF, et al. Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage. An experimental study in the immature rat. Pediatrics. 1995;95:868-874
142. Vannucci RC, Brucklacher RM, Vannucci SJ. Effect of carbon dioxide on cerebral metabolism during hypoxia-ischemia in the immature rat. Pediatr Res. 1997;42:24-29
143. van den Berg PP, Nelen WLDM, Jongsma HW, et al. Neonatal complications in newborns with an umbilical artery pH < 7.00. Am J Obstet Gynecol. 1996;175:1152-1157
144. Busto R, Dietrich WD, Globus MY-T, et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729-738
145. Clifton GL, Jiang JY, Lyeth BG, et al. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cereb Blood Flow Metab. 1991;11:114-121
146. Agardh CD, Smith ML, Siesjö BK. The influence of hypothermia on hypoglycemia-induced brain damage in the rat. Acta Neuropathol. 1992; 83:379-385
147. Morikawa E, Ginsberg MD, Dietrich WD, et al. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1992;12:380-389
148. Wass CT, Lanier WL, Hofer RE, et al. Brain changes of ≤1°C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology. 1995;83:325-335
149. Kil HY, Zhang J, Piantadosi CA. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Flow Metab. 1996;16:100-106
150. Yager J, Towfighi J, Vannucci RC. Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr Res. 1993; 34:525-529
151. Young RSK, Olenginski TP, Yagel SK, et al. The effect of graded hypothermia on hypoxic-ischemic brain damage: a neuropathologic study in the neonatal rat. Stroke. 1983;14:929-934
152. Yager JY, Asselin J. Effect of mild hypothermia on cerebral energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. Stroke. 1996;27:919-926
153. Thoresen M, Bågenholm R, Løberg EM, et al. Posthypoxic cooling of neonatal rats provides protection against brain injury. Arch Dis Child. 1996;74:F3-F9
154. Laptook AR, Corbett RJT, Sterett R, et al. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res. 1994;35:436-442
155. Thoresen M, Penrice J, Lorek A, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res. 1995;37:667-670
156. Towfighi J, Housman C, Heitjan DF, et al. The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. Acta Neuropathol. 1994;87:598-604
157. Ferry PC. Neurologic sequelae of cardiac surgery in children. Am J Dis Child. 1987;141:309-312
158. Greeley WJ, Ungerleider RM, Smith LR, et al. The effects of deep hypothermie cardiopulmonary bypass and total circulatory arrest on cerebral blood flow in infants and children. Thorac Cardiovasc Surg. 1989;97:737-745
159. Sealy WC. Hypothermia: its possible role in cardiac surgery. Ann Thorac Surg. 1989;47:788-791
160. Gidday JM, Fitzgibbons JC, Shah AR, et al. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221-224
161. Kato H, Liu Y, Araki T, et al. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res. 1991;553:238-242
162. Kirino T, Tsujita Y, Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab. 1991;11:299-307
163. Liu Y, Kato H, Nakata N, et al. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res. 1992;586:121-124
164. Vannucci RC, Duffy TE. The influence of birth on carbohydrate and energy metabolism in rat brain. Am J Physiol. 1974;226:933-940